Clinical Trial Update: Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluated chemotherapy and peripheral stem cell transplantation for myelodysplastic syndrome. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED